CooperVision Now Manufacturing Biofinity Toric Multifocal Contact Lenses in US to Speed Delivery

Wednesday, November 2 2022 | 13 h 30 min | News

To provide faster delivery to eye care professionals and their patients, CooperVision has expanded its made-to-order manufacturing at its facility in Scottsville, N.Y. to include all Biofinity^® toric multifocal contact lenses for the U.S. and Canada.

All trial lenses and six-packs of the brand’s most prescribed powers are now being produced at the site, with plans to manufacture 100% of the U.S. and Canada’s Biofinity^® toric multifocal six-pack volume within the next few months. The expansion reduces delivery times by eliminating international shipping and customs clearance steps.

All orders to service other markets will continue to be manufactured at the company’s facility in the U.K.

“The process of manufacturing a contact lens that corrects for both astigmatism and presbyopia is complex, and even more so when the available prescription options are so incredibly broad,” said Doug Brayer, Director of Marketing, Frequent Replacement Brands, CooperVision. “CooperVision’s continuous innovation and investment in manufacturing has not only made lenses like Biofinity^® toric multifocal possible, but also enables us to deliver practitioners and patients a highly customized product on an expedited timeline.”

With CooperVision’s made-to-order advantage, Biofinity^® toric multifocal lenses are available in more than 205,000 unique prescription options to ensure that eye care professionals have a lens for every patient. When using CooperVision’s OptiExpert^™ app or the fitting guide, Biofinity^® toric multifocal has a 93% success rate on initial fitting to save chair time for both ECPs and patients.

Click HERE for the full press release.